Spot Trading’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-9,780
Closed -$272K 3069
2016
Q3
$272K Buy
9,780
+1,917
+24% +$50.7K 0.01% 1889
2016
Q2
$192K Buy
7,863
+7,571
+2,593% +$215K ﹤0.01% 2251
2016
Q1
$10K Sell
292
-852
-74% -$26.8K ﹤0.01% 3140
2015
Q4
$34K Buy
+1,144
New +$38.6K ﹤0.01% 3142
2014
Q4
Sell
-393
Closed -$8.62K 4314
2014
Q3
$7K Buy
393
+185
+89% +$3.78K ﹤0.01% 4104
2014
Q2
$5K Buy
+208
New +$4.22K ﹤0.01% 4356

Other funds holding PGEN

Spot Trading's PGEN Position: Q4 2016 in Review

Spot Trading sold out of Precigen (PGEN) in Q4 2016, closing a stake of 9,780 shares — an estimated $272K sold.

Spot Trading first reported a position in PGEN in Q2 2014 and held it in 6 quarters. The position peaked at $272K in Q3 2016. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

  • Spot Trading reported no remaining Precigen position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 9,780 Precigen shares in Q4 2016, an estimated $272K.
  • Spot Trading first reported a position in Precigen in Q2 2014 and held it in 6 quarters.
  • Spot Trading's Precigen position peaked at $272K in Q3 2016.
  • 171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.